02647oam 2200817 450 991071517520332120220509115842.041-98241-98344-685(CKB)5470000002508260(OCoLC)1226424437(OCoLC)1231540475(EXLCZ)99547000000250826020201210g20202021 ua 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierUnsustainable drug prices hearing before the Committee on Oversight and Reform, House of RepresentativesWashington :U.S. Government Publishing Office,2020-2021.1 online resource (3 volumes)"One Hundred Sixteenth Congress, second session"--Pts. 1 and 2."One Hundred Seventeenth Congress, first session"--Pt. 3.Access ID (govinfo, pt. 1): CHRG-116hhrg41982.Access ID (govinfo, pt. 2): CHRG-116hhrg41983."Serial no. 116-122"--Pt. 1"Serial no. 116-123"--Pt. 2"Serial no. 117-22"--Pt. 3"September 30, 2020"--Pt. 1."October 1, 2020"--Pt. 2."May 18, 2021"--Pt. 3.Unsustainable drug prices Prescription pricingUnited StatesDrugsPricesUnited StatesPharmaceutical industryUnited StatesCostsPharmaceutical policyUnited StatesDrug developmentUnited StatesDrug developmentfastDrugsPricesfastPharmaceutical industryCostsfastPharmaceutical policyfastPrescription pricingfastUnited StatesfastLegislative hearings.fastLegislative hearings.lcgftPrescription pricingDrugsPricesPharmaceutical industryCosts.Pharmaceutical policyDrug developmentDrug development.DrugsPrices.Pharmaceutical industryCosts.Pharmaceutical policy.Prescription pricing.4.OV 2:116-123GPOGPOGPOOCLCOOCLCFDWPGPOOCLCQOCLCOGPOBOOK9910715175203321Unsustainable drug prices3522321UNINA